An experimental HIV vaccine has for the first time cut the risk of infection, researchers say.

The vaccine – a combination of two earlier experimental vaccines – was given to 16,000 people in Thailand, in the largest ever such vaccine trial.

Researchers found that it reduced by nearly a third the risk of contracting HIV, the virus that leads to Aids.